The Latest Breaking News from Nasdaq

Coherus BioSciences (NASDAQ:CHRS) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Coherus BioSciences will report an earnings per share (EPS) of $-0.48.

Within the last quarter, Coinbase Global (NASDAQ:COIN) has observed the following analyst ratings:

Texas Roadhouse (NASDAQ:TXRH) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Texas Roadhouse will report an earnings per share (EPS) of $0.91.

EyePoint Pharmaceuticals Inc (NASDAQ:EYPT) executed a license agreement with Betta Pharmaceuticals Co Ltd to develop and commercialize EYP-1901 in Mainland China, Hong Kong, Macau, and Taiwan.  This agreement expands the collaboration between EyePoint and Equinox Sciences, LLC, a Betta Pharmaceuticals affiliate established in February 2020.  EyePoint will retain global ophthalmic rights for EYP-1901 in the…

Booking Holdings's (NASDAQ:BKNG) short percent of float has risen 15.0% since its last report. The company recently reported that it has 751.20 thousand shares sold short, which is 1.84% of all regular shares that are available for trading.

Over the past 3 months, 7 analysts have published their opinion on Sage Therapeutics (NASDAQ:SAGE) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Lam Research's (NASDAQ:LRCX) short percent of float has fallen 20.47% since its last report. The company recently reported that it has 1.40 million shares sold short, which is 1.01% of all regular shares that are available for trading.

Tesla, Inc (NASDAQ: TSLA) was trading down about 2% on Wednesday, breaking bearishly from an inside bar pattern the stock had been developing. An inside bar pattern indicates a period of consolidation and is usually followed by a continuation move in the direction of the current trend.

Align Tech (NASDAQ:ALGN) has outperformed the market over the past 10 years by 13.17% on an annualized basis producing an average annual return of 24.91%. Currently, Align Tech has a market capitalization of $22.92 billion.